These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25934340)

  • 21. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic features of hepatocellular carcinoma: an analysis of 185 cases].
    Wang YL; Du JL; Shi HY; Guo AT; Wei LX
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):609-13. PubMed ID: 21122415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the serum levels of type IV collagen 7s domain and the risk of intractable ascites following liver resection for hepatocellular carcinoma: A propensity score-matched analysis.
    Shimizu A; Kobayashi A; Yokoyama T; Motoyama H; Sakai H; Kitagawa N; Notake T; Shirota T; Fukushima K; Miyagawa SI
    Surgery; 2016 Nov; 160(5):1244-1255. PubMed ID: 27503205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
    Li XM; Tang ZY; Qin LX; Zhou J; Sun HC
    J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.
    Chun JM; Kwon HJ; Sohn J; Kim SG; Park JY; Bae HI; Yun YK; Hwang YJ
    J Surg Oncol; 2011 Feb; 103(2):148-51. PubMed ID: 21259248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. -Fetoprotein in rats transplanted with ascites hepatoma.
    Watabe H; Hirai H; Sato H
    Gan; 1972 Apr; 63(2):189-99. PubMed ID: 4115995
    [No Abstract]   [Full Text] [Related]  

  • 28. Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    World J Surg; 2002 Sep; 26(9):1133-8. PubMed ID: 12209243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
    Mourad MM; Algarni A; Aly MA; Gunson BK; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MT; Bramhall SR
    Exp Clin Transplant; 2015 Aug; 13(4):333-8. PubMed ID: 26295183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
    Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resection for hepatocellular carcinoma with duodenal invasion: report of a case.
    Hatano E; Ikai I; Shimizu M; Maetani Y; Konda Y; Chiba T; Terajima H; Yamamoto N; Yamamoto Y; Shimahara Y; Yamaoka Y
    Hepatogastroenterology; 2003; 50(52):1034-6. PubMed ID: 12845974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers in hepatocellular carcinoma--letter.
    Personeni N; Rimassa L; Santoro A
    Clin Cancer Res; 2012 Sep; 18(17):4861. PubMed ID: 22859718
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined AFP-CRUT with microvascular invasion accurately predicts mortality risk in patients with hepatocellular carcinoma following curative liver resection.
    Huang GQ; Zhu GQ; Huang S; You J; Shi KQ; Hu B; Ruan LY; Zhou MT; Braddock M; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1127-38. PubMed ID: 26186642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
    Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
    Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience].
    He YF; Fan J; Zhou J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Sun J; Xiao YS; Yang GH; Song K; Wang Z; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1232-5. PubMed ID: 16796877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between serum heparanase and microscopic venous invasion in patients with hepatocellular carcinoma.
    Wang GB; Zhou XY; Wang XQ
    Am J Clin Pathol; 2010 Aug; 134(2):242-8. PubMed ID: 20660327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.
    Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.